先看重點
在8,238名45歲及以上中國成年人中,憂鬱症狀與肌少症的比值比較高(OR 1.30,95%CI 1.03-1.63),日常生活活動(ADL)障礙解釋了其中20.00%的關聯。這是按關聯進行分析的調查資料,不能證明憂鬱會導致肌肉流失。
證據類型
世代研究
解讀依據
公開摘要
閱讀重點
關聯與混雜
研究在問什麼
憂鬱和肌少症(肌肉量與功能下降)在中國中老年人中都很常見,但二者如何聯絡並不清楚。作者檢驗了日常活動困難是否位於憂鬱症狀與肌少症之間的路徑上。
研究對象與方法
分析中國健康與養老追蹤調查(CHARLS)資料,納入8,238名45歲及以上參與者(男性3,358人,女性4,880人)。用流行病學研究中心憂鬱量表評估憂鬱症狀;用logistic迴歸檢驗憂鬱症狀、ADL障礙與肌少症的關係,並校正社會活動、慢性病、人口學因素和生活方式;再用中介分析估計憂鬱與肌少症的關聯有多少經由ADL障礙。摘要未說明肌少症的判定標準。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 1憂鬱症狀與肌少症的比值比較高(OR 1.30,95%CI 1.03-1.63,P=0.0269)。
- 2ADL障礙與肌少症的關聯更強(OR 1.94,95%CI 1.37-2.75,P<0.001)。
- 3ADL障礙部分介導了憂鬱與肌少症的關聯:估計間接效應為0.006(95%CI 0.003,0.008),中介比例為20.00%。
限制與不確定性
- 1憂鬱與肌少症的測量似乎來自同一時間點,無法確定關聯的方向和中介的先後順序;也可能是肌肉流失在先、憂鬱在後。
- 2中介比例為20.00%,意味著大部分關聯並未由ADL障礙解釋;憂鬱的比值比區間也較寬(1.03-1.63)。
- 3摘要提出的心理支援加肌力訓練的建議超出了這項分析所檢驗的內容;作者自己也呼籲開展縱向研究。
- 4本解讀僅基於摘要。
日常健康啟示
在中國中老年人中,情緒低落、日常活動困難和肌肉量偏低常常同時出現,因此其中任何一項都可以提醒你留意其他兩項。這並不說明治療憂鬱就能預防肌少症;對情緒或力量的擔憂應與臨床醫師溝通。
如何連結自己的資料
握力測試不屬於常見的穿戴式資料,但手錶記錄的每日步數、步行速度和活動量可以反映日常活動能力是否在下降。請用同一裝置持續數週記錄,關注持續的下滑,而不是某一天的低值。
如何理解這類證據
暴露先於追蹤期間的結果,仍可能存在混淆和反向因果。風險比不是個人絕對風險,也不等於已證明的介入效果。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Background
Depressive symptoms and sarcopenia, often observed among middle-aged and elderly individuals, are significant health concerns in China, particularly given the country's rapidly aging population. Depressive symptoms, characterized by persistent feelings of sadness and loss of interest, can significantly impact quality of life. Little is known about the underlying pathway connecting these two conditions.
Methods
The data for this study were derived from the China Health and Retirement Longitudinal Study (CHARLS). Depressive symptoms were evaluated using the Centre for Epidemiological Studies Depression (CSED) scale. Logistic regression analyses were employed to investigate the association between depressive symptoms, activities of daily living (ADL) disability, and sarcopenia, while adjusting for potential confounding factors. The selection of predictor variables, including social activity, chronic diseases, demographic factors, and lifestyle habits, was based on their known associations with mental health, physical functioning and sarcopenia. These variables were included to ensure a comprehensive adjustment for potential confounding factors and to provide a more accurate estimation of the relationship between depressive symptoms and sarcopenia. Additionally, mediation analysis was conducted to assess the mediating role of ADL disability in the relationship between depressive symptoms and sarcopenia.
Results
A comprehensive study was conducted on a total of 8,238 participants aged 45 years and older, comprising 3,358 men and 4,880 women. Logistic regression analyses were conducted to identify significant associations between depressive symptoms (OR = 1.30, P = 0.0269,95%CI = 1.03-1.63), ADL disability (OR = 1.94, P < 0.001,95%CI = 1.37-2.75) and sarcopenia. The results revealed significant relationships among these variables. Furthermore, mediation effect analyses demonstrated that ADL disability partially mediated the association between depressive symptoms and sarcopenia (estimated indirect effect: 0.006, 95% CI: 0.003, 0.008, proportion of mediation effect: 20.00%).
Conclusions
The study underscores a significant association between depressive symptoms and sarcopenia among middle-aged and elderly individuals in China, with ADL disability acting as a mediator. These findings offer novel insights for targeted health interventions. Future interventions should effectively combat sarcopenia by integrating psychological support with muscle-strengthening exercise programs. By addressing both depressive symptoms and ADL disability, clinicians and public health professionals can enhance outcomes for this demographic. Collaborative efforts across disciplines are essential for providing comprehensive health management tailored to the needs of middle-aged and elderly individuals. Future research should longitudinally assess the impact of such integrated interventions on sarcopenia prevention and depressive symptom alleviation. Additionally, investigating the role of social and environmental factors in mediating this relationship is crucial for developing more effective health strategies for this vulnerable population.
來源與署名
Association between depressive symptoms and sarcopenia among middle-aged and elderly individuals in China: the mediation effect of activities of daily living (ADL) disability.
Li Q, Cen W, Yang T, Tao S.
BMC psychiatry · 2024-06-10
DOI: 10.1186/s12888-024-05885-y ↗PubMed · 38858698 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
ACSM綜述137項系統評價:抗阻訓練有效,影響結果的方案細節很少
美國運動醫學會彙總了137項系統評價(超過30,000名健康成年人),認為抗阻訓練在力量、肌肉量、爆發力、耐力和多項功能測試上優於不運動。能一致影響結果的方案細節很少:較大負荷(不低於單次最大重複量的80%)和2至3組有利於力量,每週至少10組有利於肌肉量,而訓練至力竭、器械型別和週期化則沒有一致影響。它彙總的是系統評價而非新試驗,沒有合併效應量,所依據的多為未經訓練者,且各評價所含的原始試驗有重疊。
Medicine & Science in Sports & Exercise
幾乎所有抗阻訓練方案都優於不運動,大負荷在力量上排名居前
一項納入隨機試驗的網狀統合分析(力量網路178項研究、5097人,肌肥大網路119項研究、3364人)顯示,幾乎所有抗阻訓練方案都優於不運動。大負荷、多組、每週至少3次的方案在力量上排名最前(標準化均數差1.60,95%可信區間1.38至1.82),大負荷、多組、每週2次的方案在肌肥大上排名最前(0.66,0.47至0.85)。多數方案之間在統計學上無法區分(91%的兩兩比較中95%可信區間包含零),且偏倚風險為中到高,因此排名只是初步參考。
British Journal of Sports Medicine
肌肉強化活動與更低的死亡、心血管病、癌症和糖尿病風險相關
彙總16項成年人前瞻性佇列研究,進行肌肉強化活動者的全因死亡風險低15%(RR 0.85,95%置信區間0.79至0.93),心血管疾病和糖尿病風險各低17%(RR均為0.83)。全因死亡曲線在每週約40分鐘時最低(RR 0.83),但更大運動量是有益還是有害尚不清楚。這些都是觀察性結果,主要來自美國的自我報告資料,作者將大多數結局的證據確定性評為極低。
British Journal of Sports Medicine
蛋白補充劑配合力量訓練:額外增益有限,年長者更少
彙總49項隨機對照試驗、1863名進行至少6週抗阻訓練的健康成年人,蛋白補充劑在單純訓練的基礎上使去脂體重多增加0.30 kg(95%置信區間0.09至0.52),使最大重複量力量多增加2.49 kg(0.64至4.33)。這些增量遠小於訓練本身的作用,年齡越大越弱,而所謂1.6 g/kg/天的平臺點沒有統計學意義(P=0.079)。有一位作者曾獲美國國家乳製品委員會資助,該機構也資助過納入分析的試驗。
British Journal of Sports Medicine

